PRE News and Press, Prenetics Global Limited From 11/30/22

LONDON and HONG KONG, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced that its board of directors has authorized a share repurchase program, and ...

Prenetics Global press release ( NASDAQ: PRE ): Q3 GAAP EPS of -$0.21 misses by $0.08 . Revenue of $79.68M (+54.1% Y/Y) beats by $13.1M . For further details see: Prenetics Global GAAP EPS of -$0.21 misses by $0.08, revenue of $79.68M beats by $13.1M

LONDON and HONG KONG, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the third quarter ended September...

Prenetics Global press release ( NASDAQ: PRE ): Q2 GAAP EPS of -$2.91. Revenue of $51.72M (-34.5% Y/Y). Adjusted EBITDA  of $6.5M Raises full year adjusted EBITDA guidance to the range of US$35 million to US$45 million, with corresponding full year revenue gui...

Revenue of US$51.7 million in the second quarter of 2022 Loss from operations of US$(17.9) million and adjusted EBITDA 1 of US$6.5 million in the same period Raises full year adjusted EBITDA guidance to the range of US$35 million to US$45 million, with corresponding full year ...

Younger Colorectal Cancer Population Highlights the Importance of Early Screening, Highly Sensitive Test Product Prenetics has Launched the Market HONG KONG, Sept 2, 2022 - (ACN Newswire) - Colorectal cancer (CRC) has become one of the main cancers threatening the health of human bein...

Citi Initiates Coverage on Prenetics Global with "Buy" Rating, Target Price at USD8.10 HONG KONG, July 13, 2022 - (ACN Newswire) - It is reported that Citi initiated coverage on Prenetics Global (PRE.US) with "Buy" rating. Target price is at USD8.10, apply 3x P/S 2023E, at parity with...

Prenetics Global  press release (NASDAQ:PRE): Q1 GAAP EPS of -$2.21 misses by $0.93. Revenue of $92M (+60.1% Y/Y) beats by $0.49M. For further details see: Prenetics Global  GAAP EPS of -$2.21 misses by $0.93, revenue of $92M beats by $0.49M

LONDON and HONG KONG, June 06, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the first quarter ended March 31,...

Prenetics becomes the first Hong Kong unicorn to list on Nasdaq and its shares began trading on May 18 under ticker “PRE” At Least US$260M of Proceeds from the Business Combination, Cash and Trade Receivables to Support Prenetics Growth Proceeds will allow ...